BioSpace News Archive

The company will use the Series A funds to develop the technology, conduct clinical studies, and pursue FDA approval.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that clinical data on its investigational BTK inhibitor zanubrutinib will be presented in two oral presentations and two posters at the 61st American Society of Hematology (ASH) Annual Meeting, taking place December 7 – 10, 2019 in Orlando, FL.

26 relapsed/refractory EBV+ PTLD patients were treated in a multicenter tab-cel® EAP study including a subgroup of 22 patients who would have likely met eligibility criteria for Atara’s ongoing tab‑cel® Phase 3 studies

Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its pioneering, proprietary ARCUS® platform, announced today that initial results from the ongoing Phase 1/2a trial of its lead investigational off-the-shelf (allogeneic) chimeric antigen receptor (CAR) T cell therapy candidate, PBCAR0191, will be presented during the 61st Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, December 7-10, 2019.

Cyclacel Pharmaceuticals, Inc. announced that data from Cyclacel’s CYC065 and sapacitabine ongoing clinical studies have been selected for presentation at the 61st American Society of Hematology Annual Meeting and Exposition in Orlando, Florida.

Ocugen, Inc. announced that it has entered into an amendment to each of the warrants issued pursuant to the Securities Purchase Agreement dated June 13, 2019 with certain Investors to restructure each of the warrants held by each such investor.

Data Reinforce Scientific Foundation of ALLO-715 (anti-BCMA) in Multiple Myeloma and ALLO-819 (anti-FLT3) in Acute Myeloid Leukemia

Findings presented at Academy of Managed Care Pharmacists (AMCP) Nexus, ISPOR Europe conferences [06-November-2019] ORLANDO, Fla. , Nov. 6, 2019 /PRNewswire/ -- AllianceRx Walgreens Prime and Duquesne University School of Pharmacy recently announced results from research analyzing data from cystic fibrosis (CF) patients prescribed cystic fibrosis transmembrane condu

Dental labs and clinics can produce dentures 75% faster with 90% lower cost using 3D Systems’ Digital Denture Workflow

Blueprint Medicines to Host Investor Event and Webcast on Sunday, December 8, 2019